The participation of chemokines in atherosclerosis

William A Boisvert1

  • 1Vascular Medicine Research, Brigham and Women's Hospital, Harvard Medical School, 65 Landsdowne Street, Cambridge, MA 02139, USA.

Discovery Medicine
|August 14, 2010
PubMed

Insights

Atherosclerosis involves plaque buildup in blood vessels. Macrophages, immune cells, are now understood to be crucial in the development of this chronic vascular disease.

Area of Science:

  • Cardiovascular Science
  • Immunology

Background:

  • Atherosclerosis is a chronic vascular disease characterized by lumen narrowing due to plaque buildup.
  • Historically, atherosclerotic plaque was attributed primarily to fat and cholesterol accumulation.

Purpose of the Study:

  • To highlight the pivotal role of immune cells in atherosclerosis pathogenesis.
  • To emphasize the current understanding of macrophage involvement in atherosclerotic plaque development.

Main Methods:

  • Review of existing literature on atherosclerosis and immunology.
  • Analysis of the cellular components and inflammatory processes within atherosclerotic plaques.

Main Results:

  • The study confirms that macrophages, a type of phagocytic immune cell, play a critical role in the pathogenesis of atherosclerosis.
  • Evidence indicates macrophages are central to the inflammatory processes driving plaque formation and progression.

Conclusions:

  • The understanding of atherosclerosis pathogenesis has evolved beyond lipid accumulation to include significant immune system involvement.
  • Macrophages are key players in the inflammatory mechanisms underlying atherosclerosis, necessitating further research into immune-targeted therapies.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...